NCT03780751

Brief Summary

Problems with sexual function are common and distressing. The most frequent sexual difficulty in women is a lack of sexual desire with a prevalence of 20-30%. When low sexual desire is experienced over several months and causes significant personal distress, a sexual dysfunction can be diagnosed (ICD-10: Hypoactive Sexual Desire Disorder: HSDD). A distressing lack of desire is reported by 6% of sexually active women. Psychological interventions are the treatment of choice for women with HSDD. Promising treatment approaches include cognitive-behavioral and mindfulness-based interventions. A recent meta-analysis also showed that Internet-delivered programs are a valid alternative to face-to-face treatments. Aim of this project to assess the effectivity of two eight-week online-programs consisting of cognitive-behavioral (COPE) and mindfulness-based (MIND) interventions for women with HSDD. Both treatments will be compared to a waitlist-control group. For this project, two well-established group-treatment manuals will be translated into German and adapted to a multimedia online-environment. All participants will be guided through the programs by well-qualified eCoaches.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
266

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

December 18, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 19, 2018

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 16, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 16, 2022

Completed
Last Updated

March 29, 2023

Status Verified

March 1, 2023

Enrollment Period

3.7 years

First QC Date

December 18, 2018

Last Update Submit

March 28, 2023

Conditions

Keywords

Sexual dysfunctionFemale Sexual Interest/Arousal DisorderInternet-based interventionMindfulnessCognitive-behavioral therapy

Outcome Measures

Primary Outcomes (1)

  • Sexual Interest and Desire Inventory Female (SIDI-F)

    The SIDI-F is a clinician-rated instrument consisting of 13 items designed to assess HSDD severity in women. A self-report version, modified for the use in partnered and unpartnered women will be applied.

    at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

Secondary Outcomes (1)

  • Female Sexual Distress Scale Revised (FSDS-R)

    at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

Other Outcomes (15)

  • Desire subscale of the Female Sexual Function Index

    at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

  • Patient Health Questionnaire 9 (PHQ-9)

    at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

  • Generalized Anxiety Disorder 7 (GAD-7)

    at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline

  • +12 more other outcomes

Study Arms (3)

Cognitive-behavioral treatment

EXPERIMENTAL

COPE-program of 8 sessions (+ 1 booster session) of guided Internet-based treatment including psychoeducation, sexual education, guided masturbation, sensate focus and cognitive-behavioral interventions (e.g., thought diaries, challenging of maladaptive thought patterns, behavioral analysis). Participants are encouraged to practice exercises between sessions.

Behavioral: Cognitive-behavioral treatment

Mindfulness-based treatment

EXPERIMENTAL

MIND-program of 8 sessions (+ 1 booster session) of guided Internet-based treatment including psychoeducation, sexual education, guided masturbation, sensate focus and mindfulness-based exercises (e.g., breathing meditation, body scan, sitting meditation).

Behavioral: Mindfulness-based treatment

Waitlist

NO INTERVENTION

Participants will receive no immediate treatment but will be able to choose either MIND or COPE after a six months waiting period.

Interventions

COPE-program of 8 sessions (+ 1 booster session) of guided Internet-based treatment including psychoeducation, sexual education, guided masturbation, sensate focus and cognitive-behavioral interventions (e.g., thought diaries, challenging of maladaptive thought patterns, behavioral analysis). Participants are encouraged to practice exercises between sessions.

Cognitive-behavioral treatment

MIND-program of 8 sessions (+ 1 booster session) of guided Internet-based treatment including psychoeducation, sexual education, guided masturbation, sensate focus and mindfulness-based exercises (e.g., breathing meditation, body scan, sitting meditation).

Mindfulness-based treatment

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • female gender
  • able to read, write and speak German
  • Meet criteria of ICD-10 criteria of Hypoactive Sexual Desire Disorder (established via online-screening and telephone interview)
  • Experience significant sexuality-related personal distress (established via online-screening and telephone interview)

You may not qualify if:

  • currently pregnant
  • ongoing medical or psychological treatment for low desire or other sexual dysfunctions or plans to enter such treatment (e.g., in-person sexual therapy, couples therapy) during study participation
  • suicide ideation (established via telephone interview)
  • currently experiencing significant symptoms of a mental disorder that might interfere with study participation (e.g., Eating Disorders, Obsessive-Compulsive Disorder, Posttraumatic Stress Disorder, Major Depression, Bipolar Disorder) as established via telephone interview
  • currently experiencing significant symptoms of a physical condition that might interfere with study participation (e.g., cancer, multiple sclerosis) as established via telephone interview
  • current Substance-Abuse Disorder
  • current or lifetime Psychotic Disorder
  • significant relationship discord or violence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruhr University Bochum

Bochum, North Rhine-Westphalia, 44787, Germany

Location

Related Publications (2)

  • Velten J, Hirschfeld G, Meyers M, Margraf J. Results of a randomized waitlist-controlled trial of online cognitive behavioral sex therapy and online mindfulness-based sex therapy for hypoactive sexual desire dysfunction in women. J Consult Clin Psychol. 2024 Nov;92(11):742-755. doi: 10.1037/ccp0000922. Epub 2024 Oct 24.

  • Meyers M, Margraf J, Velten J. Psychological Treatment of Low Sexual Desire in Women: Protocol for a Randomized, Waitlist-Controlled Trial of Internet-Based Cognitive Behavioral and Mindfulness-Based Treatments. JMIR Res Protoc. 2020 Sep 29;9(9):e20326. doi: 10.2196/20326.

MeSH Terms

Conditions

Sexual Dysfunctions, PsychologicalSexual Dysfunction, Physiological

Condition Hierarchy (Ancestors)

Mental DisordersGenital DiseasesUrogenital Diseases

Study Officials

  • Julia Velten, PhD

    Ruhr University Bochum

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are assigned to one of three groups parallel for the duration of the study. 40% of participants will be assigned to one of the two immediate treatment conditions, 20% of participants will be assigned to a waitlist and will begin active treatment after a six months waiting period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoctoral Research Associate

Study Record Dates

First Submitted

December 18, 2018

First Posted

December 19, 2018

Study Start

December 18, 2018

Primary Completion

September 16, 2022

Study Completion

September 16, 2022

Last Updated

March 29, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

IPD data of accepted publications will be published open access on the respective Journal's website or on the Open Science Framework.

Shared Documents
STUDY PROTOCOL

Locations